Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vulvar Neoplasms 2Ovarian Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Skull Base Neoplasms 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Bone Neoplasms 1Anastomotic Leak 1

Interventions

tislelizumab 7Paclitaxel 5Radiotherapy 4Carboplatin 4Oxaliplatin 3Immune Checkpoint Inhibitors 3nedaplatin 2Radiation 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cisplatin 2Albumin-Bound Paclitaxel 2tranilast 1toripalimab 1sintilimab 1irinotecan sucrosofate 1camrelizumab 1apatinib 1anlotinib 1Surgical Procedures, Operative 1Specimen Handling 1S 1 (combination) 1Robotic Surgical Procedures 1Radiosurgery 1Pemetrexed 1Patient Reported Outcome Measures 1Observation 1Nutrition Therapy 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Esophageal Neoplasms × Indocyanine Green × Clear all
NCT07406815 2026-02-12

The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy

Fujian Medical University Union Hospital

Phase 3 Not yet recruiting
144 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡